Data from the GEPIA database indicated that L3MBTL2 mRNA levels are significantly upregulated in various types of cancers, including lung cancer, liver cancer, breast cancer, skin cutaneous melanoma, and stomach adenocarcinoma (Figure S1). The gene discussed is L3MBTL2; the disease is breast cancer.